↓ Skip to main content

American Association for Cancer Research

Engineering and Therapeutic Application of Single-Chain Bivalent TGF-β Family Traps

Overview of attention for article published in Molecular Cancer Therapeutics, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
2 X users
patent
42 patents

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
28 Mendeley
Title
Engineering and Therapeutic Application of Single-Chain Bivalent TGF-β Family Traps
Published in
Molecular Cancer Therapeutics, July 2012
DOI 10.1158/1535-7163.mct-12-0060
Pubmed ID
Authors

John C. Zwaagstra, Traian Sulea, Jason Baardsnes, Anne E.G. Lenferink, Cathy Collins, Christiane Cantin, Béatrice Paul-Roc, Suzanne Grothe, Sazzad Hossain, Louis-Philippe Richer, Denis L'Abbé, Roseanne Tom, Brian Cass, Yves Durocher, Maureen D. O'Connor-McCourt

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 43%
Student > Ph. D. Student 6 21%
Student > Master 2 7%
Student > Bachelor 2 7%
Lecturer > Senior Lecturer 1 4%
Other 2 7%
Unknown 3 11%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 29%
Agricultural and Biological Sciences 5 18%
Immunology and Microbiology 3 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Chemical Engineering 1 4%
Other 4 14%
Unknown 6 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#3,391,734
of 25,837,817 outputs
Outputs from Molecular Cancer Therapeutics
#489
of 4,105 outputs
Outputs of similar age
#21,619
of 179,813 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#5
of 43 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,813 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.